Search
All
YSOPIA Bioscience, a French clinical stage biotechnology company specializing in the research and development of innovative drugs using the properties of key bacterial strains...
BiomX Inc. (NYSE American: PHGE), a clinical-stage company developing both natural and engineered phage therapies that target specific pathogenic bacteria, today announced that...
Seventure led $10M round for new French company focusing on I/O-microbiome and provided $3M seed funding to ErVaccine, driving an increased I/O microbiome focus in fund...
Proteon Pharmaceuticals announced a strategic partnership with Skretting aimed at providing functional solutions to tackle health challenges in the aquaculture industry. The...
In recent years, the understanding of how the microbiome and human health are linked has expanded considerably. We believe the rise in this understanding and the growing...
While the pandemic might have caused some disruption, microbiome research hasn’t slowed down at all, notes Isabelle de Cremoux, CEO and Managing Partner, Seventure...
European life sciences investment firm Seventure Partners has extended the final close of its second microbiome innovation fund and increased focus on advances in the skin...
A leading clinical-stage company developing a new category of therapies for immune-mediated diseases basedon rationally defined consortia of human microbiome-derived bacteria,...
Seventure Partners, one of Europe’s leaders in financing innovation and a world leader in life science microbiome investment, has increased focus on skin microbiome...
Pioneering a full-ecosystem microbiota approach to improve survival outcomes in life-threatening diseases by Hervé Affagard (Maat Pharma) published on...
